{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:31:51Z","timestamp":1771716711671,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1492,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1124\/jpet.120.000190","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T21:25:35Z","timestamp":1602192335000},"page":"439-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease"],"prefix":"10.1016","volume":"375","author":[{"given":"Gerrit","family":"Klaerner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpesh","family":"Biyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Kade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kierstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi","family":"Gbur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Tabakman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Son","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Buysse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000190_bib1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.08340812","article-title":"Effects of oral sodium bicarbonate in patients with CKD","volume":"8","author":"Abramowitz","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.mam.2012.07.009","article-title":"The SLC26 gene family of anion transporters and channels","volume":"34","author":"Alper","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1124\/jpet.120.000190_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0272-6386(97)90045-7","article-title":"The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity","volume":"29","author":"Alpern","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000190_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1053\/j.ajkd.2018.09.004","article-title":"Tolerance to sodium in patients with CKD-induced metabolic acidosis: does the accompanying anion matter?","volume":"73","author":"Bushinsky","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000190_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.07300717","article-title":"Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD","volume":"13","author":"Bushinsky","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ki.1988.183","article-title":"Cytoskeleton organization and submembranous interactions in intestinal and renal brush borders","volume":"34","author":"Coudrier","year":"1988","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000190_bib7","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib8","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.120.000190_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40620-019-00656-5","article-title":"Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study","volume":"32","author":"Di Iorio","year":"2019","journal-title":"J Nephrol"},{"key":"10.1124\/jpet.120.000190_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nep.13180","article-title":"Adenine-induced chronic kidney disease in rats","volume":"23","author":"Diwan","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"10.1124\/jpet.120.000190_bib11","first-page":"121","article-title":"Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial","volume":"35","author":"Dubey","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.120.000190_bib12","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1681\/ASN.2015040369","article-title":"Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression","volume":"27","author":"Garneata","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2215\/CJN.02450508","article-title":"Acid-base disturbances in gastrointestinal disease","volume":"3","author":"Gennari","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000500042","article-title":"Fruit and vegetable treatment of chronic kidney disease-related metabolic acidosis reduces cardiovascular risk better than sodium bicarbonate","volume":"49","author":"Goraya","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1124\/jpet.120.000190_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2215\/CJN.02430312","article-title":"A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate","volume":"8","author":"Goraya","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000190_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.ackd.2017.06.006","article-title":"Management of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Goraya","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1124\/jpet.120.000190_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MNH.0000000000000491","article-title":"Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease","volume":"28","author":"Goraya","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/jpet.120.000190_bib19","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","article-title":"Acid-base homeostasis","volume":"10","author":"Hamm","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib20","first-page":"335","article-title":"No potassium, no acid: K+ channels and gastric acid secretion","volume":"22","author":"Heitzmann","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1124\/jpet.120.000190_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0939-6411(00)00084-9","article-title":"Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?","volume":"50","author":"Jung","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.120.000190_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0002-9343(66)90182-3","article-title":"The response of normal man to selective depletion of hydrochloric acid. Factors in the genesis of persistent gastric alkalosis","volume":"40","author":"Kassirer","year":"1966","journal-title":"Am J Med"},{"key":"10.1124\/jpet.120.000190_bib23","first-page":"S86","article-title":"Metabolic alkalosis","volume":"19","author":"Khanna","year":"2006","journal-title":"J Nephrol"},{"key":"10.1124\/jpet.120.000190_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2015.08.028","article-title":"Metabolic acidosis of CKD: an update","volume":"67","author":"Kraut","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000190_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2215\/CJN.11941017","article-title":"Re-evaluation of the normal range of serum total CO2 concentration","volume":"13","author":"Kraut","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000190_bib27","first-page":"F1037","article-title":"Physiological disposal of the potential alkali load in diet of the rat: steps to achieve acid-base balance","volume":"274","author":"Lin","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.120.000190_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004836-200207000-00003","article-title":"The alkaline tide phenomenon","volume":"35","author":"Niv","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1124\/jpet.120.000190_bib30","doi-asserted-by":"crossref","first-page":"G1093","DOI":"10.1152\/ajpgi.00454.2002","article-title":"Identification of a basolateral Cl-\/HCO3- exchanger specific to gastric parietal cells","volume":"284","author":"Petrovic","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000190_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2009.519","article-title":"Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR","volume":"77","author":"Phisitkul","year":"2010","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000190_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1681\/ASN.2017040422","article-title":"Metabolic acidosis and subclinical metabolic acidosis in CKD","volume":"29","author":"Raphael","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2019030287","article-title":"A randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the BASE pilot trial","volume":"31","author":"Raphael","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fmicb.2016.00185","article-title":"Intestinal short chain fatty acids and their link with diet and human health","volume":"7","author":"R\u00edos-Covi\u00e1n","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1124\/jpet.120.000190_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/969","article-title":"Renal and intestinal absorptive defects in mice lacking the NHE3 Na+\/H+ exchanger","volume":"19","author":"Schultheis","year":"1998","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.120.000190_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ackd.2012.11.001","article-title":"Dietary acid load: a novel nutritional target in chronic kidney disease?","volume":"20","author":"Scialla","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1124\/jpet.120.000190_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/gfaa142.P0009","article-title":"P0009 Evaluation of the potential for drug interactions with veverimer","volume":"35","author":"Shao","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.120.000190_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00424-008-0495-4","article-title":"The gastric HK-ATPase: structure, function, and inhibition","volume":"457","author":"Shin","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1124\/jpet.120.000190_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ki.2013.138","article-title":"SLC26 Cl-\/HCO3- exchangers in the kidney: roles in health and disease","volume":"84","author":"Soleimani","year":"2013","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000190_bib40","series-title":"National Kidney Foundation\u2019s Primer on Kidney Diseases","first-page":"130","article-title":"Metabolic acidosis","author":"Szerlip","year":"2005"},{"key":"10.1124\/jpet.120.000190_bib41","series-title":"Fluids and Electrolytes","first-page":"201","article-title":"Metabolic acid-base disorders","author":"Toto","year":"1996"},{"key":"10.1124\/jpet.120.000190_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI106266","article-title":"Interrelationships of chloride, bicarbonate, sodium, and hydrogen transport in the human ileum","volume":"49","author":"Turnberg","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.120.000190_bib43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3109\/00365521.2013.825926","article-title":"Vomiting: a physiological response to acidosis?","volume":"48","author":"Valeur","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1124\/jpet.120.000190_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1681\/ASN.2011040430","article-title":"Sodium intake, ACE inhibition, and progression to ESRD","volume":"23","author":"Vegter","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib45","doi-asserted-by":"crossref","first-page":"G573","DOI":"10.1152\/ajpgi.00338.2001","article-title":"Identification of an apical Cl(-)\/HCO3(-) exchanger in the small intestine","volume":"282","author":"Wang","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000190_bib46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2019070677","article-title":"Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease","volume":"31","author":"Wesson","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000190_bib47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","article-title":"Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension","volume":"394","author":"Wesson","year":"2019","journal-title":"Lancet"},{"key":"10.1124\/jpet.120.000190_bib48","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(18)32562-5","article-title":"Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial","volume":"393","author":"Wesson","year":"2019","journal-title":"Lancet"},{"key":"10.1124\/jpet.120.000190_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1525-139X.2010.00752.x","article-title":"Dietary sodium in chronic kidney disease: a comprehensive approach","volume":"23","author":"Wright","year":"2010","journal-title":"Semin Dial"},{"key":"10.1124\/jpet.120.000190_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.physiol.65.072302.114200","article-title":"Cell biology of acid secretion by the parietal cell","volume":"65","author":"Yao","year":"2003","journal-title":"Annu Rev Physiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:00:47Z","timestamp":1739973647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524269640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0022356524269640"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000190","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}